Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Saw Palmetto and Improved Lower Urinary Tract Symptoms

Research synthesisLow evidenceModerate effect4 studies · 3 beneficial · 1 neutral · 0 harmful

Across 4 studies, 3 reported beneficial effects (moderate in 2 studies, small in 1) and 1 reported neutral effects for saw palmetto on improved lower urinary tract symptoms. The most-studied dose is 320 mg/day based on a 365-day randomized controlled trial in treatment-naïve men with moderate-to-severe LUTS and prostate volume >30 cc. Effect sizes were predominantly moderate.

  • Effective dose range: 320 mg/day
  • Studied populations: Men with benign prostatic hyperplasia (BPH) and moderate-to-severe lower urinary tract symptoms

Caveats: The only high-quality randomized controlled trial tested saw palmetto in combination with alfuzosin, not as monotherapy, so the effect may not generalize to saw palmetto alone. Three of the four included papers are literature reviews, which provide secondary evidence. The evidence base is small (4 studies), and conclusions should be considered preliminary.

Generated May 14, 2026
Doses used in studies
  • mg/day: 320 (median 320, IQR 320320) 1 study
Time to effect
Median: 12.2 months · IQR 12.2 months12.2 months · Range 12.2 months12.2 months — Reported in 1 of 4 studies
Safety in these studies
4 of 4 papers
Back to top